Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Quantifying Population Burden and Effectiveness of Decentralized Surveillance Strategies for Skin-Presenting Neglected Tropical Diseases, Liberia

Timothy JW, Rogers E, Halliday KE, et al. Centers for Disease Control and Prevention (CDC). Emerging Infectious Diseases. 2022; 28 (9) : 1755-1764.
Download PDF
Publication

Financing Care for Severe Stigmatizing Skin Diseases (SSSDs) in Liberia: Challenges and Opportunities

Smith JS, Diaconu K, Witter PS, et al. Research Square Platform LLC. 2022;
Download PDF
Publication

A qualitative process evaluation of a community conversation intervention to reduce stigma related to lower limb lymphoedema in Northern Ethiopia

Tora A, Kinfe M, Ali O, et al. Springer Science and Business Media LLC. BMC Health Services Research. 2022;
Download PDF
Publication

Effect of a Community-Based Holistic Care Package on Physical and Psychosocial Outcomes in People with Lower Limb Disorder Caused by Lymphatic Filariasis, Podoconiosis, and Leprosy in Ethiopia: Results from the EnDPoINT Pilot Cohort Study.

Dellar R, Ali O, Kinfe M, et al. The American journal of tropical medicine and hygiene. 2022;
Publication

Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.

Braet S, Jouet A, Aubry A, et al. The Lancet. Microbe. 2022;
Download PDF
Publication

Multibacillary leprosy with positive serology misdiagnosed as systemic lupus erythematosus.

Shoela S, Eshak N, Beltagy A, et al. BMJ case reports. 2022;
Download PDF
Publication

Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.

Negera E, Bobosha K, Aseffa A, et al. PLoS neglected tropical diseases. 2022; 16 (7) : e0010641.
Download PDF
Publication

A Historical Study of Leprosy Control Policies in Western Nigeria, 1896-1945

Onobhayedo AO. KIU Journal of Humanities. 2022; 7 (2) : 71-78.
Download PDF
Publication

Social participation restriction among persons with leprosy discharged from a multidrug therapy clinic in northern Nigeria.

Dahiru T, Iliyasu Z, Aliyu M. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022;
Download PDF
Publication

Associated factors study into the belated screening for leprosy in Benin.

Gnimavo R, Sopoh G, Djossou P, et al. PLoS neglected tropical diseases. 2022; 16 (6) : e0010533.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 24
  • Next page ››
Subscribe to African Region (AFR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD